FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
Cannabinoids Offer Modest Pain Relief but Fall Short of First-Line Status, Review Concludes
This cannabinoid analgesia review highlights modest, condition-specific pain relief from cannabinoids. Safety concerns and regulatory challenges limit their use to adjunctive therapy. Patients unresponsive to conventional treatments may consider…
Alabama’s Medical Cannabis Program Launch: What to Know
The Alabama medical cannabis program launch in May 2024 marks a significant step for patient access in a traditionally restrictive state. This program provides legal access for qualifying conditions such as epilepsy and chronic pain. Patients must…
Alabama Medical Cannabis Sales to Start in May – MJBizDaily
The Alabama medical cannabis program oversight will commence as sales start in May 2024. This oversight ensures patient access and regulatory compliance for qualifying conditions. Alabama expands treatment options with a structured medical cannabis…
Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain
If you live with chronic nerve pain, this study provides clinical evidence that full-spectrum cannabis extract chronic neuropathic pain relief can deliver meaningful benefits. A clinical study found that a full-spectrum cannabis extract containing a…